Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Continuous flow microreactors for drug discovery.

Paul Watts1

  • 1University of Hull, Department of Chemistry, Hull, UK. P.Watts@hull.ac.uk

Current Opinion in Drug Discovery & Development
|December 15, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Developing a digital ecological momentary assessment tool for 'real time' evaluation in implementation science: testing through evaluation of a novel digital social prescribing intervention.

Frontiers in public health·2026
Same author

Protocol of ASPro-PD: a phase 3 trial of ambroxol to slow progression in genetically stratified Parkinson's disease.

Journal of neurology·2026
Same author

An Umbrella Review of Quality of Life Among the General Population During the COVID-19 Pandemic.

Journal of clinical medicine·2025
Same author

Batch Synthesis of Primaquine Diphosphate Anti-Malarial Drug.

Chemistry (Weinheim an der Bergstrasse, Germany)·2025
Same author

Synthesis of Prilocaine Hydrochloride in Continuous Flow Systems.

ACS omega·2025
Same author

Exploring apprentice nursing associates' experiences of their home placements in primary care or social care.

Nursing management (Harrow, London, England : 1994)·2023
Same journal

Microreactors for continuous processing – How close to commercial utility?

Current opinion in drug discovery & development·2010
Same journal

Synthesis of polyketide natural products and analogs as promising anticancer agents.

Current opinion in drug discovery & development·2010
Same journal

Enantioselective synthesis of substituted oxindoles and spirooxindoles with applications in drug discovery.

Current opinion in drug discovery & development·2010
Same journal

Eliminating pharmaceutical impurities: Recent advances in detection techniques.

Current opinion in drug discovery & development·2010
Same journal

Stereoselective heterocycle synthesis through oxidative carbon-hydrogen bond activation.

Current opinion in drug discovery & development·2010
Same journal

Catalysis in aqueous media for the synthesis of drug-like molecules.

Current opinion in drug discovery & development·2010
See all related articles

Microreactors offer efficient organic synthesis for drug discovery. This technology enables in situ purification and integrated bioassay screening, advancing pharmaceutical intermediate production.

Area of Science:

  • Organic synthesis
  • Medicinal chemistry
  • Drug discovery

Background:

  • Microreactor technology is emerging as a powerful tool in chemical synthesis.
  • Traditional synthesis methods face challenges in scalability and efficiency for drug discovery.
  • The integration of synthesis and analysis is crucial for accelerating drug development.

Purpose of the Study:

  • To review the application of microreactors in organic and combinatorial synthesis for drug discovery.
  • To explore microreactor capabilities for in situ purification and integrated bioassay systems.
  • To assess the potential of microreactors for producing larger quantities of pharmaceutical intermediates.

Main Methods:

  • Literature review of microreactor applications in organic synthesis.

Related Experiment Videos

  • Discussion of research on microreactors with in situ purification capabilities.
  • Conceptualization of integrated microreactor-bioassay systems.

    • Main Results:

    • Microreactors facilitate efficient and controlled organic and combinatorial synthesis.
    • In situ purification within microreactors enhances compound quality and simplifies workflows.
    • Integrated systems combining microreactors and bioassays show promise for high-throughput screening.

    Conclusions:

    • Microreactor technology significantly enhances drug discovery processes through efficient synthesis and purification.
    • Integrated microreactor-bioassay systems offer a streamlined approach for compound screening.
    • Microreactors provide a scalable solution for pharmaceutical intermediate production, aiding in drug development.